Zepp Health Corporation (ZEPP)
$1.1
Rating:
Recommendation:
-
| Symbol | ZEPP |
|---|---|
| Price | $1.1 |
| Beta | 0.865 |
| Volume Avg. | 0.04M |
| Market Cap | 67.142M |
| Shares () | - |
| 52 Week Range | 1.05-2.19 |
| 1y Target Est | - |
| DCF Unlevered | ZEPP DCF -> | |
|---|---|---|
| DCF Levered | ZEPP LDCF -> | |
| ROE | -11.42% | Sell |
| ROA | -6.08% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 62.77% | Buy |
| P/E | -1.67 | Sell |
| P/B | 0.20 | Neutral |
Latest ZEPP news
About
Download (Excel)Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.